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Accepted 10 September 2019; Published online 16 September 2019AbstractObjective: This study compares participants in randomized controlled trials (RCTs) (the Minimal Invasive Treatment [MinT] trials) to
participants in a related observational study with regard to their low back pain (LBP) symptom course.
Study Design and Setting: Eligible patients were diagnosed with chronic LBP originating from the facet joints (N 5 615) or sacroiliac
(SI) joints (N 5 533) and were treated with radiofrequency denervation and an exercise program. Randomized patients were compared to
patients in the related observational study who fulfilled all RCT eligibility criteria (observational group 1) and to patients who did not fulfill
at least one of the RCT eligibility criteria (observational group 2). Outcomes were pain intensity, treatment success, and functional status
over a 3-month period. Longitudinal mixed-model analyses and linear regression models were applied to analyze the differences in out-
comes between the RCT and observational study groups.
Results: No differences in symptom course were found between patients in the RCTs and patients in observational group 1. Patients with
facet joint pain in observational group 2 had overall less treatment success (odds ratios [OR], 0.67; 95% confidence interval [CI], 0.50e0.90),
and less improvement in physical functioning (mean difference [MD], 5.82; 95% CI, 2.54e9.11) compared to the RCT patients. Patients with
SI joint pain in observational group 2 had higher pain scores (MD, 0.40; 95% CI, 0.09e0.72), less treatment success (OR, 0.72; 95% CI,
0.54e0.96), and less improvement in physical functioning (MD, 7.16; 95% CI, 3.84e10.47) compared to the RCT patients.Role of the funder/sponsor: The funders played no role in the design
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There is on-going debate whether results of randomized
controlled trials (RCTs) can be extrapolated to patients in
the routine care setting [1e4]. It has been suggested that
the willingness of patients to be randomly allocated to a
treatment differentiates these individuals from the average
patient and therefore participation in an RCT might influ-
ence the course of symptoms [5]. In addition, the strict
eligibility criteria of patients participating in RCTs chal-
lenge the generalizability of RCT results [6,7]. Results of
well-designed observational cohort studies, in turn, are pre-
sumed to resemble daily practice more closely [1e3,8,9].
This raises the question to what extent the outcomes and
symptom course in patients included in RCTs and observa-
tional studies are comparable.
Evidence generated in observational studies is often
ignored in systematic reviews as the assumption is that their
findings might be biased [2]. One recent meta-analysis
compared outcomes of RCTs and observational studies in
the field of low back pain (LBP) and showed that the clin-
ical course of LBP symptoms after a treatment in primary
care followed a pattern that was similar using both study
designs [5]. Difficulties with RCTs have also been
acknowledged in the assessment of surgical interventions
in spinal disorders, and observational studies can be a valu-
able contribution to the existing knowledge [10]. However,
it is unknown how well these comparisons between RCTs
and observational studies are transferrable to a population
of patients with chronic LBP in a secondary care setting.
The Minimal Invasive Treatment (MinT) study was de-
signed to evaluate the effectiveness and cost-effectiveness of
radiofrequency (RF) denervation added to an exercise pro-
gram for patients with chronic LBP [11]. RF denervation is
a technique that attempts to modulate neural transmission of
nociceptive stimuli, reducing spinal pain. It aims to denatu-
ralize the nerves by applying an electric current (heat). This
would prevent the conduction of nociceptive impulses
[12,13]. RF denervation is a commonly used treatment in pa-
tients with LBP originating from the facet joints and sacro-
iliac (SI) joints [14,15]. These sources of pain are also
named as mechanical LBP [16,17] and are generally assumed
to be separate sources. As such, much of the literature distin-
guishes the entities as did we in a previous publication [18].
The MinT study provides an excellent opportunity to
compare results of RCT data with observational study data
because the study consisted of three RCTs and an observa-
tional study, and the vast majority of patients in theNetherlands who were treated with RF denervation during
the inclusion period participated in the MinT study. More
details on the study design and participants can be found
in the study protocol and the publication on effectiveness
results [11,18].
The aim of this study was to assess the generalizability of
the results from RCTs by comparing the course in LBP symp-
toms over a 3-month period in (1) randomized study groups,
(2) observational study groups with patients who fulfill all
eligibility criteria of the RCTs, and (3) patients in clinical
practice who do not fulfill at least one of the eligibility criteria
for the RCTs. This design allows us to investigate the sole
impact of randomization, as well as differences in results
caused by the selection of participants in RCTs.2. Methods
2.1. Study design and setting
The MinT study was a Dutch nationwide, pragmatic
multicentre study conducted in 16 pain clinics and 102
physiotherapy practices [11]. The Medical Ethics Commit-
tee of the Erasmus University Medical Centre in Rotterdam
granted ethical approval (registration number, MEC-2012-
079). All included patients gave written informed consent.
2.2. Participants
The MinT study originally consisted of four RCTs
(including patients with (1) facet joint pain, (2) SI joint pain,
(3) a combination of symptoms, and (4) discogenic pain)
and an observational study. One trial was designed to eval-
uate RF denervation for pain from the intervertebral disks.
This trial was prematurely terminated because of a lack of
eligible patients and not included in this analysis. The data
from the RCT for patients with a combination of symptoms
was not included either because most patients in the obser-
vational study were not identified at baseline with a combi-
nation of symptoms. As such, these data could not be
extracted from the observational study. Patients in the facet
joint trial were included between January 1, 2013 and June
3, 2014. Patients in the SI joint trial were included between
January 1, 2013 and July 1, 2014 (see Table 1).
2.2.1. Observational study group inclusion criteria
Patients were eligible for the MinT study if they had
chronic (O3 months) LBP, showed no improvement of
cal Epidemiology 116 (2019) 122e132What is new?
Key findings
 This study suggests that the randomized controlled
trial (RCT) results of the MinT trials are compara-
ble to results of an observational study with a
similar intervention and population, and only small
differences are shown when the population in the
observational study differs from the RCTs.
What this adds to what was known?
 The present study adds to the existing literature
that results of pragmatic RCTs in a secondary care
setting for patients who received radiofrequency
denervation at the pain clinic are comparable to
the results of this treatment for similar patients in
daily clinical practice.
What is the implication and what should change
now?
 Our study suggests that RCTs do reflect clinical
practice when comparing similar populations and
can increase the generalizability of results. Obser-
vational studies can be taken into account when as-
sessing the symptom course after an intervention as
long as the clinical features of the intervention and
the included population are comparable.
symptoms after conservative treatment, were referred to a
pain clinic, and were able to complete Dutch question-
naires. For the analyses of the present study, patients in
the observational groups were included between the date
of the inclusion period for the RCTs closed and December
17, 2015 (see Table 1). These patients did not have the
choice to be randomized and hence resemble daily practice.
2.2.2. RCT inclusion criteria
Extra inclusion criteria for patients in the RCTs were
age between 18 and 70 years and having a positive diag-
nostic facet joint or SI joint block (50% pain reduction
30e90 minutes after procedure). Extra exclusion criteria
for the RCTs were pregnancy, anticoagulant drug therapy
and/or coagulopathy, body mass index (BMI) O 35,
124 E.T. Maas et al. / Journal of CliniTable 1. Gantt chart describing the inclusion periods for each study group
Study group 2013
Facet joint RCT January 1
SI joint RCT January 1
Facet joint observational groups 1 and 2
SI joint observational groups 1 and 2involved in a work-related conflict, and severe psychiatric
or psychological problems. These eligibility criteria used
in the study protocol were standardized and determined
by pain physicians to ensure that the study population
would be eligible for RF denervation in clinical practice
in the Netherlands.
More details on the eligibility criteria are reported in the
study protocol [11].
In summary, we compared RCT patients to patients in
the observational study, all with chronic LBP originating
from the facet joints or SI joints, receiving RF denervation,
and an exercise program:
 Randomized study group: Intervention group of the
facet joint or SI joint RCT, receiving RF denervation
and physiotherapy.
 Observational study group 1: Patients who fulfilled all
RCT eligibility criteria, but were not randomized, and
self-reported to have received RF denervation and
physiotherapy.
 Observational study group 2: Patients who did not
fulfill at least one of the RCT eligibility criteria, were
not randomized, and self-reported to have received
RF denervation and physiotherapy. These could, for
example, be patients who received RF denervation
but were older than 70 years, or with a BMI O35.2.3. Study interventions
The randomized study group received RF denervation
plus a 3-month standardized exercise program combined
with psychological support if necessary. RF denervation
included facet joint RF denervation, or Cooled RF denerva-
tion, Simplicity III probe or Palisade technique as treatment
for SI joint pain [12,19,20]. Patients were asked to refrain
from any cointervention during the 3-month intervention
period. Anesthesiologists at the participating pain clinics
recruited the patients and carried out diagnostic blocks
and RF denervation. Every participating pain clinic had a
referral agreement with physiotherapy practices in their re-
gion to provide the standardized exercise program. The
psychological interventions, if necessary, took place in a
primary care setting.
Patients in the observational study received usual care
and were monitored prospectively. For the current analysis,




June 3 December 17
July 1 December 17
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provided by a physiotherapist or exercise therapist. For pa-
tients in the observational study, this exercise program was
not standardized in time or duration.2.4. Outcomes
The three outcome measures were pain intensity (11-
point Numerical Rating Scale [NRS]) [21], functional sta-
tus (Oswestry Disability Index [ODI] 0-100) [20e22],
and treatment success (global perceived effect [GPE], 7-
point Likert scale) [23]. Treatment success measured by
the GPE scale was defined as patients reporting to be
‘‘much improved’’ or ‘‘completely recovered.’’
Minimal clinically important change scores for patients
with chronic LBP were estimated at 30% on the NRS for
pain and 8 to 12 points on the ODI for functional status
to be clinically relevant [24,25].
Age, gender, BMI, education, smoking habits, marital
status, complaint history, and patient expectations were as-
sessed on baseline. Patient expectations were assessed by
the Credibility/Expectancy Questionnaire [26]. Health care
utilization in primary and secondary care and the use of
prescribed and over-the-counter medication were assessed
by self-completed cost questionnaires [27].
All patients in the RCTs as well as observational study
received the same questionnaires and were followed up for
12 months. For this study, we used the results up to the first
3 months of follow up, as we expected a randomization effect
mostly during this 3-month intervention period. All question-
naires were web-based and sent at baseline and 3 months after
start of treatment. Pain intensity and GPE were assessed at
three and 6 weeks after start of treatment as well.2.5. Statistical methods
Baseline characteristics of patients in the RCT interven-
tion group and in the observational study were compared
using descriptive statistics. We compared the randomized
study groups pairwise to each of the two observational
study groups, separately for LBP originating from the facet
joints and SI joints. Baseline characteristics were compared
between completers and noncompleters to identify possible
selective dropout.
The analysis of mean changes for pain intensity included
all available data for each of the predetermined follow-up
assessments at 3 weeks, 6 weeks, and 3 months. To analyze
differences between the groups in pain intensity, we used a
maximum likelihood estimation from longitudinal linear
mixed-effects models under ‘‘missing at random’’ assump-
tions, and included a fixed term for pain clinic if necessary,
based on the likelihood ratio test [28]. This fixed term for
pain clinic was added to the model only for analyzing pa-
tients with facet joint pain.
For treatment success (dichotomous outcome), we used
a generalized linear mixed model (logit link) with the samemultilevel structure under ‘‘missing at random’’ assump-
tions and also included a fixed term for pain clinic if neces-
sary, based on the likelihood ratio test [28]. This fixed term
for pain clinic was added to the model for analyzing both
patients with facet joint pain and SI joint pain.
Functional status was assessed at 3 months only.
Analyzing differences in functional status was performed
using a linear regression model.
For all analyses, we calculated regression coefficients or
odds ratios with 95% confidence intervals and performed an
unadjusted analysis and an analysis adjusted for baseline
outcomes. We included time*group interactions in all
models, and time-specific associations are presented,
regardless of the statistical significance of these interaction
terms. We used MLwiN to analyze the data (V2.22).
We preplanned a complete-case analysis as sensitivity
analysis, including complete cases from the RCT (Facet
RCT N5 98; SI joint RCT N5 87) and complete cases from
the 3- and 6-week measurements in the observational groups
(facet joint observational study group 1, N5 268; facet joint
observational study group 2. N 5 295; SI joint observational
study group 1, N 5 187; SI joint observational study group
2,N5 235). In the observational study groups,we selected pa-
tients based on self-reported RF denervation and physio-
therapy. Self-reported treatments were assessed at the end of
the 3-month online questionnaire. In this questionnaire, the
outcomes were measured before the treatments and because
participants were instructed to answer each question to
continue the questionnaire, there were no missing data in
any of the outcomes for the observational groups at 3 months.3. Results
In total, 7,529 patients were included in one of the RCTs
or the observational group in the MinT study between
January 1, 2013 and December 17, 2015. Most patients
were excluded from the RCTs because of psychological
problems (i.e., depressive symptoms or anxiety) or because
they were older than 70 years; for a complete overview of
exclusions, see Appendix A.
In total, 1,148 patients fulfilled the eligibility criteria for
the present study (see Figure 1). Of the patients with LBP
originating from the facet joints, 125 patients were random-
ized to the intervention group, 257 patients participated in
observational group 1 (fulfilling all of the RCT eligibility
criteria), and 233 patients participated in observational group
2 (not fulfilling the RCT eligibility criteria). Of the patients
with LBP originating from the SI joints, 116 patients were
randomized to the intervention group, 198 patients in obser-
vational group 1, and 219 in observational study group 2.3.1. Patient characteristics
Baseline characteristics are shown in Table 2. The total
study population had a mean age of 55.6 years (SD 13.4),
Fig. 1. Flow chart. SI, sacroiliac; RF, radiofrequency; RCT, randomized controlled trial.
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ried, and had on average 13 years (SD 12.5) of LBP symp-
toms. During the 3-month follow-up, most of the patients
visited primary care more than 10 times, visited the outpa-
tient clinic at least once, and were never hospitalized
(Table 3). On average, 20% of the patients used weak opi-
oids and 4e18% used strong opioids (Table 3).
Patients in observational study group 2 were somewhat
older, had a lower education level, less likely to have a paid
job, had slightly more functional limitations at baseline,
and more often used strong opioids compared with random-
ized patients and patients in observational study group 1
(Tables 2e4). This applied to patients with chronic LBP
originating from the facet joints and the SI joints.
There were hardly any differences between completers
and noncompleters in baseline characteristics, health care
use, medication, and outcomes (Appendix B and
Appendix C). The number of complete cases ranged from
77% to 89% between the groups (Figure 1).
3.2. Comparison between randomized patients and
patients in the observational study
3.2.1. Facet joints
The mean pain intensity for patients with LBP origi-
nating from the facet joints in the first 3 weeks after RF
denervation decreased by 1.97 points (on an 11-point scale)
in the randomized study group, 2.07 points in observationalgroup 1, and 1.76 in observational group 2. Pain intensity
stabilized afterward (Table 4 and Figure 2).
3.2.1.1. Comparing observational group 1 with the RCT.
We found no statistically significant or clinically relevant
differences in the course of symptoms based on pain, func-
tional status, and treatment success between patients in
observational study group 1 and randomized patients
(Table 4 and Figure 2).
3.2.1.2. Comparing observational group 2 with the RCT.
No statistical significantly or clinically relevant differences
in improvement in pain intensity between patients in obser-
vational study group 2 and randomized patients were found.
Statistically significantly less improvement in functional
status in patients was shown in observational study group
2 compared with randomized patients (mean difference
[MD] 5.82; 95% CI: 2.54e9.11) on a 0e100 scale. Howev-
er, this difference is not considered clinically relevant
(i.e., ! 8 to 12 points on the ODI). We found a smaller
treatment success in observational study group 2 compared
with the RCT overall and at each time point (three and
6 weeks, and 3 months after intervention) (Table 4).3.2.2. SI joints
The mean pain intensity for patients with LBP origi-
nating from the SI joints decreased 2.21 points in
Table 2. Descriptive baseline characteristicsdchronic LBP originating from the facet joints and the SI joints
Characteristics
Patients with chronic LBP originating from the facet






1 N [ 257
Observational
group






1 N [ 188
Observational
group
2 N [ 219
Age, mean (SD), y 52.9 (11.5) 53.3 (11.04) 62.7 (13.91) 51.6 (10.9) 51.4 (11.0) 57.4 (15.6)
Women, No. (%) 65 (55.6%) 163 (63.4%) 144 (61.8%) 87 (75.0%) 150 (79.8%) 165 (78.2%)
BMI, mean (SD) 26.7 (5.2) 27.1 (3.8) 29.0 (5.8) 26.7 (4.2) 26.5 (3.8) 28.9 (6.3)
Smoker, No. (%) 34 (29.1%) 67 (26.1%) 51 (21.9%) 29 (26.6%) 42 (22.3%) 50 (23.7%)
Education level, No. (%)b
 Low 57 (48.7%) 116 (45.1%) 136 (58.4%) 59 (54.1%) 80 (42.6%) 119 (56.9%)
 Moderate 35 (29.9%) 80 (31.1%) 50 (21.5%) 32 (29.4%) 74 (39.4%) 62 (29.7%)
 High 21 (17.9%) 61 (23.7%) 47 (20.2%) 18 (16.5%) 34 (18.1%) 28 (13.4%)
History of back pain complaints,
median (IQR), months
 Time since first experience
with low back pain
146 (50e267) 122 (37e244) 137 (50e266) 97 (37e228) 122(37e241) 164 (37e244)
 Time since first current episode
with low back pain
31 (12e103) 30 (12e67) 48 (13e122) 30 (12e76) 30 (12e85) 30 (12e73)
Married or living with a partner,
No. (%)
93 (74.4%) 215 (83.7%) 166 (71.2%) 85 (78.0%) 143 (76.1%) 143 (68.1%)
CEQ score, mean (SD)c
 Credibility (0e27) 21.4 (3.9) 21.4 (4.2) 21.4 (3.9) 21.4 (4.5) 22.6 (3.2) 21.4 (4.0)
 Expectancy (0e27) 18.9 (4.6) 18.7 (4.7) 18.1 (4.6) 18.8 (4.9) 19.5 (4.3) 18.2 (4.8)
Having a paid job (%) 64 (51.2%) 144 (56.3%) 47 (20.2%) 66 (61.7%) 107 (54.0%) 70 (32.6%)
Abbreviations: LBP, low back pain; SI, sacroiliac; SD, standard deviation; No., number; BMI, body mass index (calculated as weight in kilo-
grams divided by height in meters squared); IQR, interquartile range; CEQ, credibility expectancy questionnaire; CLBP, chronic low back pain.
a Results are presented of the patients who had complete baseline data.
b Education levels: Low indicates preschool, primary school, or lower secondary school; moderate indicates higher secondary school or under-
graduate; high indicates tertiary, university, or postgraduate.
c A higher score indicates more credibility in the effectiveness of treatment or higher expectations about the treatment (score range, 0e27).
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denervation, 2.31 points in observational group 1, and 2.05
points in observational group 2. This stabilized afterward
(Table 4 and Figure 2).
3.2.2.1. Comparing observational group 1 with the RCT.
We found no differences in course of LBP symptoms based
on pain, functional status, and treatment success between
patients in observational study group 1 and randomized
patients.
3.2.2.2. Comparing observational group 2 with the RCT.
Participants in observational study group 2 had statistically
significant less pain reduction overall (MD, 0.40; 95% CI:
0.09e0.72) on a 0e10 scale, and at the 3-month assessment
as well (MD, 0.58; 95% CI 0.05e1.11). However, these
MDs are small and not considered clinically relevant
(i.e., ! 30% on the NRS for pain intensity). Participants
in observational study group 2 also had less improvement
in functional status (MD, 7.16; 95% CI: 3.84e10.47) on
a 0e100 scale over the 3-month period and overall less
treatment success (OR, 0.72; CI: 0.54e0.96) comparedwith randomized patients. These differences are not consid-
ered clinically relevant either.3.3. Sensitivity analysis
The percentage of patients with LBP originating from
the facet joints who had complete data on all measurement
points was almost 10% higher in the observational study
compared with the randomized study groups (78.4% in
the RCT vs. 88.3% in observational study group 1 and
89.0% in observational study group 1, respectively).
Among patients with chronic LBP originating from the SI
joints, the percentage of complete cases was 75.0% in the
randomized study group and 76.8% and 77.6% in both
study groups, respectively (see Figure 1).
We found merely negligible differences between the
main analysis and complete case analysis (Appendix D).
Models without adjustments for baseline outcome differ-
ences (Appendix E) showed similar results in pain intensity
and showed larger MDs between the observational study
groups and the randomized study groups in ODI scores. One
explanation for this could be regression to the mean because
Table 3. Descriptive health care and medication usedLBP originating from the facet joints and the SI joints
Characteristics






1 N [ 257
Observational
group






1 N [ 198
Observational
group
2 N [ 219
Primary care visits
 0 (%) 12 (10.1%) 0 (0.0%) 0 (0.0%) 0 (0%) 0 (0.0%) 0 (0.0%)
 !10 (%) 27 (22.7%) 108 (42.0%) 94 (40.3%) 32 (29.4%) 95 (48.0%) 98 (44.7%)
 10 (%) 80 (67.2%) 149 (58.0%) 139 (59.7%) 77 (70.6%) 103 (52.0%) 121 (55.3%)
Outpatient clinic
 0 (%) 49 (41.2%) 79 (30.7%) 71 (30.5%) 43 (39.4%) 73 (36.9%) 70 (32.0%)
 1 (%) 70 (58.8%) 178 (69.3%) 162 (62.5%) 66 (56.9%) 125 (63.1%) 149 (68.0%)
One-day treatment
 0 (%) 77 (64.7%) 141 (54.9%) 145 (62.2%) 62 (56.9%) 117 (59.1%) 132 (60.3%)
 1 (%) 42 (35.3%) 116 (45.1%) 88 (37.8%) 47 (43.1%) 81 (40.9%) 87 (39.7%)
Hospitalization
 0 (%) 119 (100.0%) 252 (98.1%) 230 (98.7%) 108 (99.1%) 193 (97.5%) 218 (99.5%)




46 (39.7%) 77 (30.0%) 59 (25.3%) 37 (34.3%) 54 (27.3%) 60 (27.4%)
 Nonopioids (%) (aspirin/
paracetamol/NSAIDs)
42 (36.2%) 104 (40.5%) 77 (33.0%) 53 (38.9%) 81 (40.9%) 78 (35.6%)
 Weak opioids (%) (with or
without nonopioids)
23 (19.8%) 46 (17.9%) 54 (23.2%) 24 (22.2%) 41 (20.7%) 48 (21.9%)
 Strong opioids (%) (with or
without nonopioids)
5 (4.3%) 28 (10.9%) 41 (17.6%) 5 (4.6%) 21 (10.6%) 29 (13.2%)
Abbreviations: LBP, low back pain; SI, sacroiliac; NSAIDS, Nonsteroidal anti-inflammatory drugs; CLBP, chronic low back pain.
Table 4. Outcomes of the observational study groups compared with the randomized study groups
Overall effects












Overall difference 0.17 (0.57; 0.22) 0.35 (0.05; 0.75)
Baseline 7.14 (1.38) 7.11 (1.395) 7.55 (1.38)
3 Weeks 5.17 (2.27) 5.04 (2.156) 0.28 (0.76; 0.21) 5.79 (2.09) 0.29 (0.20; 0.79)
6 Weeks 5.19 (2.31) 5.02 (2.25) 0.22 (0.69; 0.25) 5.66 (1.99) 0.26 (0.22; 0.74)
3 Months 5.01 (2.29) 5.00 (2.350) 0.04 (0.50; 0.43) 5.68 (2.13) 0.40 (0.11; 0.92)
ODI functioning (SD)
Baseline 35.08 (14.66) 28.24 (14.05) 46.07 (14.89)
3 Months 26.03 (16.58) 30.53 (16.57) 1.47 (1.67; 4.60) 40.21 (17.55) 5.82 (2.54; 9.11)
OR (95% CI) OR (95% CI)
Treatment success (%)
Overall difference 0.99 (0.75; 1.3) 0.67 (0.50; 0.90)
3 Weeks 32 (29.6%) 63 (27.5%) 0.90 (0.54; 1.49) 45 (21.1%) 0.64 (0.38; 1.08)
6 Weeks 35 (29.4%) 81 (32.1%) 1.14 (0.71; 1.83) 60 (26.7%) 0.87 (0.53; 1.43)
3 Months 43 (36.1%) 89 (34.6%) 0.94 (0.59; 1.48) 55 (23.6%) 0.55 (0.34; 0.88)
Values presented are means with corresponding standard deviations (SDs), percentages of recovered patients, and model estimates of linear
mixed-effects models with a random intercept, adjusted for pain intensity and functional status at baseline. Regression coefficients can be
interpreted as mean differences between both observational groups compared to the RCT at a certain follow-up moment compared to baseline.
Abbreviations: OR, odds ratio; NRS, Numeric Rating Scale (0e10); GPE, global perceived effect; ODI, Oswestry Disability Index (0-100);
CLBP, chronic low back pain.
Higher score indicates more severe symptoms.
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Fig. 2. Course in low back pain symptoms at baseline until 3-month follow-up. CI, confidence interval.
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intensity score and more limitations in functional status.4. Discussion
4.1. Main results
This study compared the symptom course between ran-








7.17 (1.65) 7.56 (1.33)
4.96 (2.19) 5.25 (2.20) 0.13 (0.45;
5.22 (2.16) 4.89 (2.23) 0.45 (0.99;
4.77 (2.46) 5.17 (2.38) 0.27 (0.27;
38.07 (14.07) 41.01 (13.39)
27.72 (17.05) 31.33 (15.01) 1.98 (1.33;
OR (95% C
0.93 (0.70; 1
28 (29.8%) 47 (29.7%) 0.98 (0.56; 1
40 (37.0%) 63 (33.2%) 0.84 (0.51; 1
43 (39.1%) 77 (38.9%) 0.98 (0.61; 1patients with chronic LBP originating from the facet joints
or SI joints who were treated with RF denervation and an
exercise program. Our results suggest that these patients
experience similar levels of pain and functioning and
improvement whether randomized to a treatment group or
undergoing treatment in an observational study as long as
all patients fulfill eligibility criteria. When this is not the
case (i.e., patients did not fulfill all the inclusion criteria),





0.30) 0.40 (0.09; 0.72)
7.46 (1.44)
0.72) 5.41 (2.34) 0.38 (0.19; 0.95)
0.09) 5.60 (2.26) 0.25 (0.28; 0.78)
0.80) 5.45 (2.27) 0.58 (0.05; 1.11)
46.22 (13.73)
5.29) 39.94 (16.95) 7.16 (3.84; 10.47)
I) OR (95% CI)
.25) 0.72 (0.54; 0.96)
.72) 47 (26.4%) 0.83 (0.48; 1.45)
.38) 61 (28.5%) 0.68 (0.42; 1.11)
.57) 67 (30.6%) 0.68 (0.42; 1.09)
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pain intensity score, more limitations in functional status,
and less treatment success compared with randomized pa-
tients. Descriptive statistics showed that patients who did
not fulfill all RCT inclusion criteria were somewhat older,
had a lower education level, were less likely to have a paid
job, had slightly more functional limitations at baseline,
and more often used strong opioids compared with random-
ized patients and patients who did meet all RCT inclusion
criteria. These patients were more likely to have a slightly
worse symptom course, which might imply that the results
of the RCT are a minor overestimation of the results in real
life (which we consider a real-life combination of patients
in observational groups 1 and 2).
Previous studies estimated minimal change scores for
patients with LBP of 30% on the NRS for pain, and 8 to
12 points on the ODI for functional status to be clinically
relevant [24,25]. All study groups in our study showed
average changes less than 30% on the NRS for pain inten-
sity and less than 10 points in functional status over time on
the ODI. The differences between the randomized and
observational study groups in the present study cannot be
considered clinically relevant.
All in all, this study suggests that (1) the RCT results of
the MinT trials reflect clinical practice in a similar popula-
tion and (2) participants in the RCT show slightly better re-
sults compared with the observational group in clinical
practice that does not meet all eligibility criteria. This study
adds to the current literature that results of pragmatic RCTs
(more specifically, the clinical course of patients in the
intervention arm) in a secondary care setting for patients
who received RF denervation at the pain clinic are compa-
rable to the clinical course after this treatment for similar
patients in daily clinical practice.4.2. Strengths and limitations
A strength of the present study is the nationwide study
design, which resulted in a large sample of patients who
were recruited in routine clinical care. Second, patients
who were randomly allocated to be treated with RF dener-
vation and an exercise program could be compared with pa-
tients who received a similar treatment but had a treatment
choice in the observational study groups. This increased the
applicability of the results in clinical practice, which is
probably the average of the outcomes in observational
groups 1 and 2. In other words, it shows that the symptom
course is probably not affected by randomization. This sup-
ports the generalizability of the RCT results.
A limitation of this study was the inability to select a
proper control group that was more or less comparable to
the control group in the RCT, using the observational data.
The variety of physiotherapy treatments would have made
it impossible to select a group of patients with a compara-
ble treatment as the standardized exercise program in the
RCT control group. Therefore, it was not possible toperform a nonrandomized comparison of RF denervation
in addition to an exercise program vs. an exercise program
alone. Various studies and one meta-analysis performed a
nonrandomized treatment comparison in the field of LBP
[29e32]. These studies showed similar results in clinical
course of LBP symptoms compared with the present study.
However, these previous studies analyzed a variety of
mostly conservative treatments, and clinical heterogeneity
could potentially have influenced the results.
Second, a reference standard for diagnosing facet joint
or SI joint pain is not available [14]. In this pragmatic
study, diagnostic tests that are commonly applied in clinical
practice were used. Controversy concerning the ideal
threshold value of pain reduction in the diagnostic blocks
exists. A 50% cutoff has most frequently been used in pre-
vious studies [14] and in clinical practice. Performing two
or more independent diagnostic blocks decreases the false-
positive rate but increases the number of false-negative
blocks [33]. Furthermore, a clinical trial showed that mul-
tiple blocks are not cost-effective [31].
Third, other patients may present themselves at the pain
clinic in daily practice compared with the patients we
included in the present study. However, the inclusion criteria
of the RCTs are in line with treatment criteria in daily prac-
tice, and more importantly, the vast majority of patients in
the Netherlands who were treated with RF denervation dur-
ing the inclusion period participated in the MinT study. This
was the result of a governmental regulation that only patients
who participated in the MinT study were reimbursed for the
treatment costs by their health insurance company. For that
reason, we expect that patients in this study reflect patients
in clinical practice more closely.
Fourth, the relatively large attrition is a potential limita-
tion. However, most of the attrition is explained by the se-
lection of patients with diagnosed SI and facet joint pain
who were included in the observational study after the
RCT inclusion period was closed. However, there was a
relatively large number of dropouts at 12 months. Although
we did not define differences between the complete-case
analysis and the intention-to-treat analysis using all data,
it is possible that completers are different from noncomp-
leters, which could have biased the results of the
complete-case analyses.4.3. Reflections
Systematic reviews in health care often ignore the evi-
dence generated in observational studies, as the general
assumption is that observational studies overestimate the
effects of treatments tested in RCTs [2,34]. Moreover,
observational findings are more likely to be biased and
are based on studies that lack a comparable control group.
The difference in results between RCTs and observational
studies are usually attributed to differences in methodolog-
ical quality. A recent meta-analysis provides evidence to
the contrary [35]. This meta-analysis examined factors that
131E.T. Maas et al. / Journal of Clinical Epidemiology 116 (2019) 122e132explain heterogeneity in clinical outcomes in the field of
LBP, of which study design is one of the factors. The au-
thors concluded that other effect modifiers were frequently
more powerful explanatory variables than study design.
These factors included pain duration, involvement of
workers’ compensation, presence of spondylolisthesis,
levels fused, and previous surgery [35]. The results of the
meta-analysis are in line with our results and suggest that
differences between RCTs and observational study results
in the field of LBP are primarily attributable to clinical fac-
tors and not by the difference in study design. More data
have become available that show similar clinical course re-
sults from observational studies and RCTs in fields outside
[2,36e38], as well as inside the field of LBP [5,35]. The re-
sults of our study seem to support these findings.
We acknowledge differences in techniques between
countries and settings. Needle size and placement, duration,
and temperature of RF denervation could be some of these
differences. We encourage researchers and clinicians in
other countries or settings to evaluate whether these proced-
ures reflect their daily practice. Second, researchers can
consider matching (e.g., by propensity score matching or
coarsened exact matching) on demographic characteristics
of patients in observational studies and patients in RCTs
to further investigate randomization bias.
Most LBP studies show small treatment effects and the
clinical course in symptoms tend to improve in the first
6 weeks, reaching a plateau over the following 12 months
[39,40]. Our study results are in line with these findings
in previous literature. It seems more likely that differences
between study results can be attributed to study setting,
population, intervention, or other discrepancies between
studies and not to study design itself [41]. We encourage
future research using data from routine clinical care (real-
life data). This might be promising for evaluating effective-
ness of clinical interventions in situations when performing
an RCT is complex or unethical, but methodological chal-
lenges need to be addressed, such as, for example, con-
founding by indication.5. Conclusion
Despite the belief that observational studies are assumed
to overestimate the effects of interventions evaluated in
RCTs, our study showed fairly similar outcomes in pain,
functioning, and treatment success after RF denervation
over a 3-month time in patients with chronic LBP origi-
nating from the facet joints and SI joints in a randomized
study treatment population compared with similar patients
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